Marcazzan, Sabrina http://orcid.org/0000-0002-4483-810X
Braz Carvalho, Marcos J.
Nguyen, Nghia T.
Strangmann, Julia
Slotta-Huspenina, Julia
Tenditnaya, Anna http://orcid.org/0000-0002-8421-4991
Tschurtschenthaler, Markus http://orcid.org/0000-0002-0060-4790
Rieder, Jonas
Proaño-Vasco, Andrea
Ntziachristos, Vasilis
Steiger, Katja http://orcid.org/0000-0002-7269-5433
Gorpas, Dimitris http://orcid.org/0000-0001-9576-8087
Quante, Michael
Kossatz, Susanne http://orcid.org/0000-0002-1908-1782
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 824 (B05: 68647618))
Technische Universität München
Article History
Received: 25 October 2023
Accepted: 22 January 2024
First Online: 21 February 2024
Declarations
:
: Organoids and human FFPE tissues were obtained within the BarretNET registry, which was approved by the ethics committee of the Technical University Hospital of Munich (#5291/12). All animal experiments were performed following protocols approved by the Regierung von Oberbayern (ROB 55.2–2532.Vet_02-15–29, Vet_02-20–69, and Vet_02-16–24) according to the German Animal Welfare Act and Ethical Guidelines of the Klinikum rechts der Isar, Technical University of Munich (TUM).
: N/A.
: S.K. is a shareholder of Summit Biomedical Imaging, LLC. SK is a co- inventor on PCT application WO2016164771. V.N. is a founder and equity owner of sThesis GmbH, iThera Medical GmbH, Spear UG and I3 Inc. All other authors have no relevant conflict of interest to declare.